You are here

Article info

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0210 CD16+ Nk Cells Are Persistently Increased after Rituximab Therapy in Rheumatoid Arthritis Patients

Authors

Citation

Giollo A, Viapiana O, Carletto A, et al
FRI0210 CD16+ Nk Cells Are Persistently Increased after Rituximab Therapy in Rheumatoid Arthritis Patients
Annals of the Rheumatic Diseases 2016;75:507-508.

Publication history

  • First published July 15, 2016.
Online issue publication 
February 26, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions